Osaka, Japan

Koichiro Fukuoka




Average Co-Inventor Count = 3.6

ph-index = 4

Forward Citations = 44(Granted Patents)


Company Filing History:


Years Active: 2001-2024

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Koichiro Fukuoka: Innovator in Thienopyrimidine Derivatives

Introduction

Koichiro Fukuoka is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of thienopyrimidine derivatives. With a total of 7 patents to his name, Fukuoka's work has had a notable impact on medical science.

Latest Patents

Fukuoka's latest patents include innovative methods for producing thienopyrimidine derivatives that exhibit gonadotropin-releasing hormone (GnRH) antagonistic action. One of his key inventions provides a production method that ensures high quality and yield of these derivatives. The method involves the reaction of specific chemical compounds, including 6-(4-aminophenyl)-1-(2,6-difluorobenzyl)-5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione, along with 1,1'-carbonyldiimidazole and methoxyamine.

Career Highlights

Throughout his career, Fukuoka has worked with notable companies such as Takeda Pharmaceutical Company Limited and Takeda Chemical Industries, Inc. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations.

Collaborations

Fukuoka has collaborated with esteemed colleagues, including Kazuhiro Miwa and Shokyo Miki. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Koichiro Fukuoka's contributions to the field of pharmaceuticals, particularly through his patents on thienopyrimidine derivatives, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…